Daklinza for HIV co-infected patients
The summary of product characteristics of Daklinza (daclatasvir; Bristol-Myers Squibb) has been updated to reflect the results of a study, which found the medicine is effective at treating hepatitis C when patients are also infected with HIV. This includes changes to the posology and information on interactions with other medicines.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069475
Recommended from Pharmaceutical Press